Search

Your search keyword '"Egorov VV"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Egorov VV" Remove constraint Author: "Egorov VV"
96 results on '"Egorov VV"'

Search Results

1. Viscosity and thermal conductivity of nanofluids

2. Molecular dynamics simulation of plane poiseuille flow in nanochannels

3. Effects of scorpion (Buthus eupeus) toxins on cyclic AMP and cyclic GMP levels in brain and heart tissues

4. Spontaneous formation of different forms of alpha-synuclein fibrils from a recombinant protein.

5. H + -Selective Electrodes Based on Amine-Type Ionophores: Generalized Theory and A Priori Quantification of Lower and Upper Detection Limits.

6. Matrix is everywhere: extracellular DNA is a link between biofilm and mineralization in Bacillus cereus planktonic lifestyle.

7. Inside and outside of virus-like particles HBc and HBc/4M2e: A comprehensive study of the structure.

8. A feasible, fast and reliable method for estimating ion-site association constants in plasticized PVC ion-selective electrode membranes.

9. [Optical coherence tomography angiography in diagnosis of changes in macular capillary blood flow in chronic ischemic retinopathy].

10. Caught red handed: modeling and confirmation of the myeloperoxidase ceruloplasmin alpha-thrombin complex.

11. Determination of Single-Ion Partition Coefficients between Water and Plasticized PVC Membrane Using Equilibrium-Based Techniques.

12. Heterotrophic Microbiota from the Oligotrophic Waters of Lake Vostok, Antarctica.

13. Old dog, new tricks: Influenza A virus NS1 and in vitro fibrillogenesis.

14. Cold and distant: structural features of the nucleoprotein complex of a cold-adapted influenza A virus strain.

15. [Functional rehabilitation of patients after endovitreal surgery of rhegmatogenous retinal detachment with complete retinal attachment].

16. Quantum-classical mechanics as an alternative to quantum mechanics in molecular and chemical physics.

17. Effect of alpha-lactalbumin and lactoferrin oleic acid complexes on chromatin structural organization.

19. Overcoming of One More Pitfall in Boundary Element Calculations with Computer Simulations of Ion-Selective Electrode Response.

20. Changing times: Fluorescence-lifetime analysis of amyloidogenic SF-IAPP fusion protein.

21. [Herpesviral infection as an etiological factor of acute idiopathic optic neuritis].

22. Application of the interface equilibria-triggered dynamic diffusion model of the boundary potential for the numerical simulation of neutral carrier-based ion-selective electrodes response.

23. Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure.

24. CROSS-PROTECTIVE PROPERTIES OF AN INFLUENZA VACCINE BASED ON HBC4M2E RECOMBINANT PROTEIN.

25. The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity.

26. An Interface Equilibria-Triggered Time-Dependent Diffusion Model of the Boundary Potential and Its Application for the Numerical Simulation of the Ion-Selective Electrode Response in Real Systems.

27. COMPARISON OF INFLUENZA A VIRUS INHIBITION IN VITRO BY SIRNA COMPLEXES WITH CHITOSAN DERIVATIVES, POLYETHYLENEIMINE AND HYBRID POLYARGININE-INORGANIC MICROCAPSULES.

28. Nature of the optical band shapes in polymethine dyes and H-aggregates: dozy chaos and excitons. Comparison with dimers, H*- and J-aggregates.

29. [Optic nerve pathology in the structure of diagnostic errors inpatients referred for cataract surgery].

30. [Objective method to recognize warning signs in peripheral vitreoretinal dystrophies].

31. [The pathochemical characteristics of oligomeric forms of Tamm-Horsfall protein under urolithiasis].

32. The influenza A virus NS genome segment displays lineage-specific patterns in predicted RNA secondary structure.

33. [Adenosine A2A receptor as a drug target for treatment of sepsis].

34. [INTERACTION OF THE DYE CONGO RED WITH FIBRILS OF LYSOZYME, BETA2-MICROGLOBULIN AND TRANSTHYRETIN].

35. [Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents].

36. [Diagnostic errors when referring patients for cataract surgery].

37. Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.

38. Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins.

39. Improved separate solution method for determination of low selectivity coefficients.

40. A conservative mutant of a proteolytic fragment produced during fibril formation enhances fibrillogenesis.

41. [Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses].

42. Amyloidogenic peptide homologous to fragment 129-148 of human myocilin.

43. Structural Features of the Peptide Homologous to 6-25 Fragment of Influenza A PB1 Protein.

44. Magnetic labeling of proteins for atomic force microscopy.

45. Mass spectrometry and biochemical analysis of RNA polymerase II: targeting by protein phosphatase-1.

46. Expression in E. coli and purification of the fibrillogenic fusion proteins TTR-sfGFP and β2M-sfGFP.

47. [Stress protection therapy in the prevention of macular morphological lesions in patients with diabetes mellitus at cataract microsurgery].

48. [Clinical and morphometric macular changes in patients with diabetes mellitus after cataract phacoemulsification].

49. [Transillumination-assisted phlebectomy with the help of the TriVex system in comprehensive management of varicose disease of lower-limb veins].

50. Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin.

Catalog

Books, media, physical & digital resources